Tumor-infiltrating lymphocyte therapy for lung cancer and its future paradigms

Introduction Lung cancer is the leading cause of cancer death, with an estimated 1.8 million deaths contributing to this cancer in 2020. Despite advances in treatment options and various approaches being attempted, the survival rate remains low.